Lake Street Advisors Group LLC Sells 144 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX)

Lake Street Advisors Group LLC decreased its position in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 9.7% during the third quarter, Holdings Channel reports. The institutional investor owned 1,339 shares of the company’s stock after selling 144 shares during the period. Lake Street Advisors Group LLC’s holdings in IDEXX Laboratories were worth $677,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of IDXX. OneAscent Wealth Management LLC purchased a new stake in shares of IDEXX Laboratories in the first quarter worth about $206,000. Vicus Capital purchased a new position in shares of IDEXX Laboratories in the first quarter valued at $210,000. Aviance Capital Partners LLC purchased a new stake in IDEXX Laboratories during the first quarter valued at $405,000. Oak Thistle LLC bought a new position in IDEXX Laboratories during the first quarter valued at $297,000. Finally, Allspring Global Investments Holdings LLC grew its stake in shares of IDEXX Laboratories by 10.5% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 40,771 shares of the company’s stock worth $22,013,000 after buying an additional 3,886 shares in the last quarter. Institutional investors own 87.84% of the company’s stock.

IDEXX Laboratories Stock Down 0.2 %

Shares of NASDAQ:IDXX opened at $451.41 on Friday. The company has a quick ratio of 1.03, a current ratio of 1.37 and a debt-to-equity ratio of 0.33. The business’s 50 day moving average is $485.44 and its 200 day moving average is $489.97. The stock has a market cap of $37.16 billion, a P/E ratio of 44.69, a price-to-earnings-growth ratio of 4.03 and a beta of 1.33. IDEXX Laboratories, Inc. has a 52-week low of $372.50 and a 52-week high of $583.39.

IDEXX Laboratories (NASDAQ:IDXX) last announced its quarterly earnings results on Tuesday, August 6th. The company reported $2.44 EPS for the quarter, missing the consensus estimate of $2.88 by ($0.44). IDEXX Laboratories had a net margin of 22.34% and a return on equity of 57.03%. The firm had revenue of $1 billion for the quarter, compared to analysts’ expectations of $1.01 billion. During the same quarter in the prior year, the business posted $2.67 EPS. The business’s quarterly revenue was up 6.4% on a year-over-year basis. Sell-side analysts predict that IDEXX Laboratories, Inc. will post 10.44 EPS for the current year.

Analysts Set New Price Targets

Several analysts have recently issued reports on IDXX shares. JPMorgan Chase & Co. decreased their target price on shares of IDEXX Laboratories from $630.00 to $575.00 and set an “overweight” rating on the stock in a research report on Friday, October 11th. Piper Sandler decreased their price objective on IDEXX Laboratories from $600.00 to $520.00 and set a “neutral” rating on the stock in a research report on Wednesday, August 14th. Stifel Nicolaus dropped their target price on IDEXX Laboratories from $510.00 to $500.00 and set a “hold” rating for the company in a report on Thursday, October 10th. StockNews.com lowered IDEXX Laboratories from a “buy” rating to a “hold” rating in a report on Wednesday, July 10th. Finally, BTIG Research assumed coverage on IDEXX Laboratories in a research report on Thursday, July 25th. They issued a “buy” rating and a $580.00 price target for the company. Three analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat.com, IDEXX Laboratories currently has a consensus rating of “Moderate Buy” and an average price target of $574.13.

IDEXX Laboratories Company Profile

IDEXX Laboratories, Inc develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy.